Clinical Trial Update: Antithymocyte Globulin and Cyclosporine in Treating Patients With Myelodysplastic Syndrome [Phase 3]

View source ↗

Summary

A Phase 3 clinical trial evaluating antithymocyte globulin combined with cyclosporine for treating myelodysplastic syndromes has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Myelodysplastic Syndromes

Drugs mentioned

• Antithymocyte Globulin (anti-thymocyte globulin)
• CYCLOSPORINE (cyclosporine)

Snippet

Sponsor: Swiss Cancer Institute | Conditions: Myelodysplastic Syndromes | Phase 3 | Status: COMPLETED